Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (23)

« Back to Publications

Interferon-Gamma–Producing CD8+ Tissue Resident Memory T Cells Are a Targetable Hallmark of Immune Checkpoint Inhibitor–Colitis

Sasson SC. et al, (2021), Gastroenterology, 161, 1229 - 1244.e9

Checkpoint-blocker-induced autoimmunity is associated with favourable outcome in metastatic melanoma and distinct T-cell expression profiles

Ye W. et al, (2021), British Journal of Cancer, 124, 1661 - 1669

Therapeutic Decisions in Inflammatory Bowel Disease in the SARS-Cov-2 Pandemic

Brain O. and Satsangi J., (2021), Gastroenterology, 160, 1883 - 1884

Immunotherapy-related hepatitis: real-world experience from a tertiary centre

Cheung V. et al, (2019), Frontline Gastroenterology, 10, 364 - 371

Another Case of Reflux Esophagitis?

Chapman TP. et al, (2019), Gastroenterology, 157, 309 - 310

Real-time data monitoring for ulcerative colitis: patient perception and qualitative analysis

Walsh A. et al, (2019), Intestinal Research, 17, 365 - 374

Anorexia, vomiting and weight loss in a 22-year-old woman

Cheung VTF. et al, (2019), Gut, 68, 803 - 927

Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and Histological Disease Activity in Ulcerative Colitis—a Prospective Analysis

Walsh A. et al, (2019), Journal of Crohn's and Colitis, 13, 424 - 430

Real-world data: the incidence, diagnosis, and management outcomes of patients with immunotherapy-related colitis in two tertiary centres

Cheung V. et al, (2019), JOURNAL OF CROHNS & COLITIS, 13, S137 - S138

Can patients enter the 'Standard Set' ICHOM parameters by completing electronic questionnaires?

Walsh A. et al, (2019), JOURNAL OF CROHNS & COLITIS, 13, S140 - S141

Could an escalation of therapy or intervention (ETI) calculator be used to triage appointments for patients with ulcerative colitis?

Walsh A. et al, (2019), JOURNAL OF CROHNS & COLITIS, 13, S397 - S398

DEVELOPING AN INDEX THAT PREDICTS ESCALATION OF THERAPY AT AN OUTPATIENT APPOINTMENT IN PATIENTS WITH KNOWN ULCERATIVE COLITIS (UC)

Walsh A. et al, (2018), GASTROENTEROLOGY, 154, S587 - S587

Development of an index that predicts escalation of therapy at an outpatient appointment in patients with known ulcerative colitis (UC)

Walsh A. et al, (2018), JOURNAL OF CROHNS & COLITIS, 12, S321 - S321

Should extraintestinal manifestations (EIMs) be part of disease activity assessment in ulcerative colitis?

Walsh A. et al, (2018), JOURNAL OF CROHNS & COLITIS, 12, S461 - S461

Can daily SCCAI measurements over a 6-month period better phenotype the pattern of disease in ulcerative colitis?

Walsh A. et al, (2018), JOURNAL OF CROHNS & COLITIS, 12, S359 - S360

Load More